Published in J Sci Res Med Sci on October 01, 2001
Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists. Bioorg Med Chem (2010) 0.81
A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis. Autophagy (2016) 0.75
Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull (1997) 13.33
The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28
Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81
Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci (1990) 8.61
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (1996) 7.26
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature (1990) 6.18
Multiple receptors for dopamine. Nature (1979) 5.51
Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry (1991) 5.36
Selegiline as initial treatment in de novo parkinsonian patients. Neurology (1992) 4.75
Multiple dopamine D4 receptor variants in the human population. Nature (1992) 4.08
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science (1976) 4.07
Clozapine. A novel antipsychotic agent. N Engl J Med (1991) 3.72
Cloning and expression of a rat D2 dopamine receptor cDNA. Nature (1989) 3.59
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry (2001) 3.20
Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry (1996) 3.05
The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci (1992) 2.89
Brain dopamine receptors. Pharmacol Rev (1980) 2.88
Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature (1976) 2.85
Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci (1990) 2.83
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther (1989) 2.78
Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Arch Gen Psychiatry (1996) 2.76
Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet (1995) 2.54
Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry (1996) 2.49
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature (1991) 2.41
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet (1989) 2.25
Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res (1991) 2.21
Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc Natl Acad Sci U S A (1989) 2.10
Dopamine D4 receptors elevated in schizophrenia. Nature (1993) 2.09
Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature (1990) 2.04
Molecular diversity of the dopamine receptors. Annu Rev Pharmacol Toxicol (1993) 1.89
Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci U S A (1990) 1.87
Biochemical pathophysiology of Parkinson's disease. Adv Neurol (1987) 1.87
Novel dopamine receptors half a decade later. Trends Pharmacol Sci (1995) 1.86
Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry (1999) 1.85
Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell (1997) 1.83
Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry (1997) 1.80
Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc Natl Acad Sci U S A (1992) 1.76
Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature (1990) 1.75
Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology (1998) 1.70
Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatr (Phila) (1997) 1.66
Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry (1987) 1.65
Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature (1990) 1.60
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur J Pharmacol (1992) 1.57
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) (1989) 1.55
Effects of newer antipsychotics on extrapyramidal function. CNS Drugs (2002) 1.50
DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J Neurosci (1986) 1.49
Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem (1993) 1.46
New atypical antipsychotic medications. J Psychiatr Res (1998) 1.44
Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: a preliminary report based on psychiatric interviews. Proc Annu Meet Am Psychopathol Assoc (1975) 1.36
Mechanisms of signal transduction at the dopamine D2 receptor. Trends Pharmacol Sci (1989) 1.32
Functional deficits in basal ganglia of children with attention-deficit/hyperactivity disorder shown with functional magnetic resonance imaging relaxometry. Nat Med (2000) 1.28
Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes. Proc Natl Acad Sci U S A (1990) 1.27
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord (2000) 1.18
MPTP: current concepts and controversies. Clin Neuropharmacol (1986) 1.16
Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Ann Neurol (1990) 1.13
The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics (1992) 1.12
Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem (1986) 1.11
Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol (1993) 1.11
[Gene cloning of human dopaminergic D3 receptor and identification of its chromosome]. C R Acad Sci III (1990) 1.11
Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc Natl Acad Sci U S A (1991) 1.05
Oxidation reactions in Parkinson's disease. Neurology (1990) 1.05
Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment. Arch Gen Psychiatry (1987) 1.04
Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol (2001) 1.02
Neuropathology of Parkinson's disease and related syndromes. Neurol Clin (1992) 1.00
Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction. Biol Psychiatry (1989) 1.00
Problems associated with long-term levodopa treatment of Parkinson's disease. Acta Neurol Scand Suppl (1983) 0.98
A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci U S A (1995) 0.97
Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology (1994) 0.97
Cell transplantation for the treatment of Parkinson's disease. Semin Neurol (2001) 0.97
Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J Neurosci (1997) 0.96
Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol Pharmacol (1991) 0.96
Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. J Pharmacol Exp Ther (1997) 0.96
Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. Biochem Biophys Res Commun (1991) 0.95
Distribution of D5 dopamine receptor mRNA in rat brain. Neurosci Lett (1992) 0.94
Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry (1999) 0.94
Epidemiology of Parkinson's disease. Neurol Clin (1992) 0.94
The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). N Engl J Med (1985) 0.92
Long-term effects of olanzapine, risperidone, and quetiapine on dopamine receptor types in regions of rat brain: implications for antipsychotic drug treatment. J Pharmacol Exp Ther (2001) 0.92
Neuroleptic malignant syndrome: a review of the literature. J Clin Psychopharmacol (1986) 0.92
Stereotactic pallidotomy in the treatment of Parkinson disease: an expert opinion. Arch Neurol (1999) 0.91
Thirty years of dopamine research. Adv Neurol (1993) 0.91
Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annu Rev Neurosci (1980) 0.91
Impact of adversity on functioning and comorbidity in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1995) 0.89
The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells. Mol Pharmacol (1994) 0.88
Differential origins of spinothalamic tract projections to medial and lateral thalamus in the rat. J Comp Neurol (1979) 0.88
Dopamine D4 receptors: significance for molecular psychiatry at the millennium. Mol Psychiatry (1999) 0.88
D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J Biol Chem (1994) 0.88
New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology (1995) 0.86
Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. J Pharmacol Exp Ther (1997) 0.85
Intracerebral adrenal medulla grafts: a review. Exp Neurol (1990) 0.85
Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia. J Neurosci (1995) 0.84
Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions. J Neurosci Res (1999) 0.84
Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. Neuropsychopharmacology (2001) 0.84
Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment. Neuroscience (1997) 0.83
Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev (1991) 0.82
Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor. N Engl J Med (1972) 0.82
Location cloning strategy for characterizing genetic defects in Huntington's disease and Alzheimer's disease. FASEB J (1989) 0.82
Role of genetics in the cause of Parkinson's disease. Mov Disord (1998) 0.81